What drives the pre-market gain in SHLTN.SW stock?

Early buying appears linked to renewed interest in SHL’s partnerships and a technical bounce from the 50-day average. Low float and small market cap can magnify moves. Watch volume and news flow for confirmation.

What is Meyka AI's grade for SHLTN.SW?

Meyka AI rates SHLTN.SW with a score out of 100: **65.75 — Grade B — Suggestion: HOLD**. This factors sector comparison, growth, metrics, forecasts and consensus.

What price targets and forecasts exist for SHLTN.SW?

Meyka AI's forecast model projects monthly **CHF 1.17**, quarterly **CHF 1.34**, and yearly **CHF 1.1095**. Suggested conservative target **CHF 1.60**, bull **CHF 2.20**, downside **CHF 0.90**.

Is SHLTN.SW stock suitable for long-term portfolios?

SHLTN.SW may suit risk-tolerant investors seeking healthcare exposure and small-cap upside. Ongoing losses, limited liquidity, and operational risk make it unsuitable for conservative, income-focused portfolios.

CH Stocks

SHLTN.SW SHL Telemedicine (SIX) +4.89% pre-market 09 Jan 2026: CHF1.18 insight

ByHuzaifa Zahoor January 9, 2026January 9, 2026

SHLTN.SW stock opened higher pre-market on 09 Jan 2026, trading at CHF 1.18 and showing a +4.89% move on volume 78,716. The jump puts SHL Telemedicine Ltd. (SIX) among early top gainers in Swiss trading. Investors are watching earnings cues, recent device partnerships, and short-term technical signals as drivers of today’s move.